Abstract
Ocular graft-versus-host disease is one of the most severe forms of ocular surface disease. Inflammation is clearly the underlying pathophysiologic mechanism that leads to the development and progression of the disease. The cases below highlight the latest diagnostic and management strategies as well as the potential complications of this condition. Autologous serum/plasma tears, along with anti-inflammatory therapy, continue to be the main topical treatment options to help control the symptoms and modulate inflammation. Scleral contact lenses are currently the most effective treatment option, and an effective strategy is to offer this option to patients earlier rather than later in the disease course.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ogawa Y, et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep. 2013;3:3419. PMC. Web. 29 2015
Dastjerdi MH, Hamrah P, Al-Arfaj K, Dana R. Disparate corneal nerve alterations between the two eyes in dry eye patients with asymmetric ocular surface manifestations: in vivo confocal microscopy Study. Invest Ophthalmol Vis Sci. 2008;49(13):5315.
Russo PA, Bouchard CS, Galasso JM. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Eye Contact Lens. 2007;33:144–7.
Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58(3):233–51.
Lelli GJ Jr, Musch DC, Gupta A, et al. Ophthalmic cyclosporine use in ocular GVHD. Cornea. 2006;25:635–8.
Pflugfelder SC. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):163–78.
Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea. 2007;26(10):1195–9.
DeLoss KS, et al. PROSE treatment for ocular chronic graft-versus-host disease as a clinical network expands. Eye Contact Lens. 2015;42(4):262–6.
Theodore FH, Ferry AP. Superior limbic keratoconjunctivitis: clinical and pathological correlations. Arch Ophthalmol. 1970;84:481–4.
Yang HY, Fujishima H, Toda I, et al. Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol. 1997;124:80–7.
Sivaraman KR, Jivrajka RV, Soin K, Bouchard CS, Movahedan A, Shorter E, Jain S, Jacobs DS, Djalilian AR. Superior limbic keratoconjunctivitis-like inflammation in patients with chronic graft-versus-host disease. Ocul Surf. 2016;14(3):393–400.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Soin, K., Djalilian, A.R., Jain, S. (2018). Diagnosis and Management of Ocular Graft-Versus-Host Disease. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-15823-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15822-8
Online ISBN: 978-3-319-15823-5
eBook Packages: MedicineMedicine (R0)